December - 2019

MECFA Blog

Vertex and Republic of Ireland Reach Agreement on Reimbursement for Triple Combination Therapy

Patients with cystic fibrosis (CF) in the Republic of Ireland will be among the first in Europe to benefit from Vertex Pharmaceuticals’...

Care of Children with Bronchiectasis Lags Those with Cystic Fibrosis, Australian Study Finds

Children with bronchiectasis have poorer lung function than those with (CF), likely because of the u8differing levels of care given to...

The immune system listens in on bacteria signaling to each other

The immune response can be modulated by bacterial signaling molecules. One bacterium does not an infection cause; the microbes work as a...

IGF2R Blood Levels May Help Predict Antibiotic Response in CF Pulmonary Exacerbations, Study Says

Measuring the levels of insulin-like growth factor 2 receptor (IGF2R) during the first days of treatment with intravenous antibiotics...

Proteostasis to Test Personalized Treatment with Novel CFTR Modulators in Europe

Three investigative therapies by Proteostasis Therapeutics — PTI-801, PTI-808, and PTI-428 — showed potential to treat cystic fibrosis...

Approval of drug therapy a 'new dawn' for cystic fibrosis care in Ireland

A drug which has the potential to treat the underlying cause of cystic fibrosis for 80% of patients in Ireland has been approved by the...

Medical News Today: Celiac disease may be treated with cystic fibrosis drugs

New research investigates the molecular similarities between celiac disease and cystic fibrosis. The results suggest that a compound...

New technology for protein bioconjugation and structural proteomics

Researchers at the Czech Academy of Sciences and the Brno-based start-up CF Plus Chemicals, a spin-off of ETH Zurich, has reported a new...

What are the benefits of NAC?

N-acetylcysteine (NAC) is a supplement that has been available for several decades. People take it for various reasons, including to help...

Israeli, US Researchers Develop New Device to Eliminate Mucus Secretion from Obstructed Airways

Researchers in Israel and the U.S. have developed a new technology that can be used to unclog and eliminate mucus secretions from the...

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds